Fact CheckerSign in

NCT07297420Completed

Peri-Intubation Adverse Airway Events in Critically Ill Patients With Morbid and Super Obesity

Peri-Intubation Adverse Airway Events in Critically Ill Patients With Morbid and Super Obesity: A Retrospective Analysis

Source: ClinicalTrials.gov · Last updated 6 Oct 2026

Brief summary (registry, in English)

This study aims to compare the incidence and characteristics of peri-intubation adverse airway events in critically ill trauma patients with morbid obesity versus those with super obesity, and to determine whether increasing BMI independently predicts severe peri-intubation complications.

Status (registry)
Completed
Study type
Observational
Enrollment
223 (actual)
First submitted
24 Nov 2025
Start date
23 Apr 2026
Primary completion date
30 May 2026
Lead sponsor
Zeliha Alicikus
Diseases
Obesity
NCT number
NCT07297420

What you commit to

  • Study type: Observational
  • Participants enrolled: 223
  • From 23 Apr 2026 to the primary completion date, 30 May 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Age

  • Age \< 18 years

Other

  • BMI\<40
  • No intubation
  • Incomplete or missing medical records

Who the study is looking for

  • Age ≥ 18 years
  • BMI ≥40
  • Admission to the surgical ICU and intubated during ICU stay
  • Availability of complete clinical data

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
UF Health Jacksonville (Shands Hospital)
Coordinator of this site? Confirm its status
JacksonvilleUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.